Your browser doesn't support javascript.
Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study.
Falcone, Marco; Tiseo, Giusy; Giordano, Cesira; Leonildi, Alessandro; Menichini, Melissa; Vecchione, Alessandra; Pistello, Mauro; Guarracino, Fabio; Ghiadoni, Lorenzo; Forfori, Francesco; Barnini, Simona; Menichetti, Francesco.
  • Falcone M; Infectious Disease Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Tiseo G; Infectious Disease Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Giordano C; Microbiology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
  • Leonildi A; Infectious Disease Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Menichini M; Microbiology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
  • Vecchione A; Microbiology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
  • Pistello M; Virology Unit, Department of Laboratory Medicine Pisa University Hospital and Retrovirus Center, Department of Translational Research, University of Pisa, Pisa, Italy.
  • Guarracino F; Department of Anaesthesia and Critical Care Medicine, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
  • Ghiadoni L; Emergency Medicine Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Forfori F; Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.
  • Barnini S; Microbiology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
  • Menichetti F; Infectious Disease Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
J Antimicrob Chemother ; 76(4): 1078-1084, 2021 03 12.
Article in English | MEDLINE | ID: covidwho-998365
ABSTRACT

BACKGROUND:

Bacterial and fungal superinfections may complicate the course of hospitalized patients with COVID-19.

OBJECTIVES:

To identify predictors of superinfections in COVID-19.

METHODS:

Prospective, observational study including patients with COVID-19 consecutively admitted to the University Hospital of Pisa, Italy, between 4 March and 30 April 2020. Clinical data and outcomes were registered. Superinfection was defined as a bacterial or fungal infection that occurred ≥48 h after hospital admission. A multivariate analysis was performed to identify factors independently associated with superinfections.

RESULTS:

Overall, 315 patients with COVID-19 were hospitalized and 109 episodes of superinfections were documented in 69 (21.9%) patients. The median time from admission to superinfection was 19 days (range 11-29.75). Superinfections were caused by Enterobacterales (44.9%), non-fermenting Gram-negative bacilli (15.6%), Gram-positive bacteria (15.6%) and fungi (5.5%). Polymicrobial infections accounted for 18.3%. Predictors of superinfections were intestinal colonization by carbapenem-resistant Enterobacterales (OR 16.03, 95% CI 6.5-39.5, P < 0.001); invasive mechanical ventilation (OR 5.6, 95% CI 2.4-13.1, P < 0.001); immunomodulatory agents (tocilizumab/baricitinib) (OR 5.09, 95% CI 2.2-11.8, P < 0.001); C-reactive protein on admission >7 mg/dl (OR 3.59, 95% CI 1.7-7.7, P = 0.001); and previous treatment with piperacillin/tazobactam (OR 2.85, 95% CI 1.1-7.2, P = 0.028). Length of hospital stay was longer in patients who developed superinfections ompared with those who did not (30 versus 11 days, P < 0.001), while mortality rates were similar (18.8% versus 23.2%, P = 0.445).

CONCLUSIONS:

The risk of bacterial and fungal superinfections in COVID-19 is consistent. Patients who need empiric broad-spectrum antibiotics and immunomodulant drugs should be carefully selected. Infection control rules must be reinforced.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Superinfection / Cross Infection / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: J Antimicrob Chemother Year: 2021 Document Type: Article Affiliation country: Jac

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Superinfection / Cross Infection / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: J Antimicrob Chemother Year: 2021 Document Type: Article Affiliation country: Jac